Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy

Open access
Giorgi Rossi, Paolo, Marino, Massimiliano, Formisano, Debora, Venturelli, Francesco, Vicentini, Massimo, Grilli, Roberto, the Reggio Emilia COVID-19 Working Group·2020·PLOS ONE

Published version of a preprint

Abstract

Abstract Objectives To describe the age- and sex-specific prevalence of SARS-CoV-2 disease (COVID-19) and its prognostic factors. Design Population-based prospective cohort study on archive data. Setting Preventive services and hospital care in the province of Reggio Emilia, Northern Italy. Participants All 2653 symptomatic patients who tested positive for SARS-CoV-2 from February 27 to April 2, 2020 in the province of Reggio Emilia. Main outcome measures Hospitalization and death up to April 2, 2020. Results Females had higher prevalence of infection than males below age 50 (2.61 vs. 1.84 ‰), but lower in older ages (16.49 vs. 20.86 ‰ over age 80). Case fatality rate reached 20.7% (22/106) in cases with more than 4 weeks follow up. After adjusting for age and comorbidities, men had a higher risk of hospitalization (hazard ratio (HR) 1.4 95% confidence interval (95% CI) 1.2 to 1.6) and of death (HR 1.6, 95% CI 1.2 to 2.1). Patients over age 80 compared to < age 50 had HR 7.1 (95% CI 5.4 to 9.3) and HR 27.8 (95% CI 12.5 to 61.7) for hospitalization and death, respectively. Immigrants had a higher risk of hospitalization (HR 1.3, 95% CI 0.99 to 1.81) than Italians and a similar risk of death. Risk of hospitalization and of death were higher in patients with heart failure (HR 1.6, 95% CI 1.2 to 2.1and HR 2.3, 95% CI 1.6 to 3.2, respectively), arrhythmia (HR 1.5, 95% CI 1.2 to 1.9 and HR 1.8, 95% CI 1.3 to 2.5, respectively), dementia (HR 1.2, 95% CI 0.9 to 1.8 and HR 1.8, 95% CI 1.1 to 2.8, respectively), ischemic heart disease (HR 1.3, 95% CI 1.0 to 1.7 and HR 1.7, 95% CI 1.2 to 2.5, respectively), diabetes (HR 1.5, 95% CI 1.3 to 1.9 and HR 1.6, 95% CI 1.1 to 2.2, respectively), and hypertensions(HR 1.4, 95% CI 1.2 to 2.6 and HR 1.6, 95% CI 1.2 to 2.1, respectively), while COPD increased the risk of hospitalization (HR 1.9, 95% CI 1.4 to 2.5) but not of death (HR 1.1, 95% CI 0.7 to 1.7). Previous use of ACE inhibitors has no effect on risk of death (HR 0.97, 95% CI 0.69 to 1.34) Conclusions The mechanisms underlying these associations are mostly unknown. A deeper understanding of the causal chain from infection, disease onset, and immune response to outcomes may explain how these prognostic factors act.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0238281

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 22

  1. J Yuan, 2020, Monitoring Transmissibility and Mortality of COVID-19 in Europe, Int J Infect Dis
  2. Y Liu, 2020, The reproductive number of COVID-19 is higher compared to SARS coronavirus, J Travel Med
  3. A Saglietto, 2020, COVID-19 in Europe: the Italian lesson, Lancet, s0140-6736, 30690
  4. Cereda D, Tirani M, Rovida F, et al. The early phase of the COVID-19 outbreak in Lombardy, Italy. arXiv.org—Quant Biol Published Online First: March 20, 2020. http://arxiv.org/abs/2003.09320 (accessed 4 Apr 2020). · arXiv
  5. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)—China, 2020. China: 2020. http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51 (accessed 4 Apr 2020). · DOI · Paper page
  6. W Guan, 2020, Clinical Characteristics of Coronavirus Disease 2019 in China, N Engl J Med
  7. L Fang, 2020, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med, 8, e21, 10.1016/S2213-2600(20)30116-8 · DOI · Paper page
  8. ME Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 · DOI · Paper page
  9. A Abdi, 2020, Diabetes and COVID-19: A systematic review on the current evidences, Diabetes Res Clin Pract, 166, 108347, 10.1016/j.diabres.2020.108347 · DOI · Paper page
  10. X Fang, 2020, Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis, Aging (Albany NY), 12, 12493, 10.18632/aging.103579 · DOI · Paper page
  11. Giorgi Rossi P, Ferroni E, Spila Alegiani S, et al. Survival of hospitalized COVID-19 patients in Northern Italy: a population-based cohort study by the ITA-COVID19 Network. medRxiv 2020.05.15.20103119; https://doi.org/10.1101/2020.05.15.20103119 · doi:10.1101/2020.05.15.20103119
  12. DD Rajgor, 2020, The many estimates of the COVID-19 case fatality rate, Lancet Infect Dis, 20, 776, 10.1016/S1473-3099(20)30244-9 · DOI · Paper page
  13. Emilia-Romagna COVID-19 working group, 2020, Case fatality rate in patients with COVID-19 infection and its relationship with length of follow up, J Clin Virol, 128, 104415, 10.1016/j.jcv.2020.104415 · doi:10.1016/j.jcv.2020.104415
  14. C Pinto, 2020, SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia, Biology (Basel), 9, E181
  15. F Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 · DOI · Paper page
  16. J jin Zhang, Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China, Allergy Eur J Allergy Clin Immunol, 2020
  17. N Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 · DOI · Paper page
  18. L Wang, 2020, Coronavirus Disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up, J Infect
  19. X Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, 0
  20. B Pacelli, 2016, Differences in mortality by immigrant status in Italy. Results of the Italian Network of Longitudinal Metropolitan Studies, Eur J Epidemiol, 31, 691, 10.1007/s10654-016-0177-z · DOI
  21. A Petrelli, The health status of the immigrant population in Italy: evidence from multipurpose surveys of the Italian National Institute of Statistics (Istat), Epidemiol Prev, 41, 1
  22. A Shet, 2020, Differential COVID-19-attributable mortality and BCG vaccine use in countries, medRxiv

Cited by

See all 171

Metadata

Authors
Giorgi Rossi, P., Marino, M., Formisano, D., Venturelli, F., Vicentini, M., Grilli, R., & the Reggio Emilia COVID-19 Working Group
Venue
PLOS ONE
Published
2020-08-27
Volume
15
Issue
8
Pages
e0238281
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3080783441
Cited by
171
References
3
FWCI
4.71
Type
journal article
Language
en
Open access
gold
Funders
  • Azienda USL-IRCCS di Reggio Emilia
  • Ministero della Salute (COVID-2020-12371808)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy. https://app.cochat.ai/papers/10.1371/journal.pone.0238281
The paper
Giorgi Rossi, P., Marino, M., Formisano, D., Venturelli, F., Vicentini, M., Grilli, R., & the Reggio Emilia COVID-19 Working Group. (2020). Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy. PLOS ONE. https://doi.org/10.1371/journal.pone.0238281

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.